Lantheus Holdings, Inc. (LNTH)
NASDAQ: LNTH · Real-Time Price · USD
78.23
-2.61 (-3.23%)
At close: Feb 21, 2025, 4:00 PM
80.00
+1.77 (2.26%)
After-hours: Feb 21, 2025, 5:57 PM EST
Lantheus Holdings Market Cap
Lantheus Holdings has a market cap or net worth of $5.44 billion as of February 21, 2025. Its market cap has increased by 46.90% in one year.
Market Cap
5.44B
Enterprise Value
5.19B
1-Year Change
46.90%
Ranking
Category
Stock Price
$78.23
Market Cap Chart
Since June 25, 2015, Lantheus Holdings's market cap has increased from $178.90M to $5.44B, an increase of 2,940.29%. That is a compound annual growth rate of 42.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 5.62B | -9.64% |
| Dec 31, 2024 | 6.22B | 46.48% |
| Dec 29, 2023 | 4.25B | 21.06% |
| Dec 30, 2022 | 3.51B | 79.37% |
| Dec 31, 2021 | 1.96B | 116.78% |
| Dec 31, 2020 | 902.10M | 12.06% |
| Dec 31, 2019 | 805.00M | 33.72% |
| Dec 31, 2018 | 602.00M | -21.51% |
| Dec 29, 2017 | 767.00M | 149.67% |
| Dec 30, 2016 | 307.20M | 188.72% |
| Dec 31, 2015 | 106.40M | -40.53% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.92B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |